Guidelines

Oncology

 SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PET (2023)

 International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology (2023)

 Joint EANM/SNMMI/IHPBA procedure guideline for [99mTc]Tc-mebrofenin hepatobiliary scintigraphy SPECT/CT in the quantitative assessment of the future liver remnant function (2023)

 SNMMI Procedure Standard/EANM Practice Guideline for Palliative Nuclear Medicine Therapies of Bone Metastases (2023)

Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT) (2023)

SNMMI Procedure Standard/EANM Practice Guideline for SSTR Receptor PET: Imaging Neuroendocrine Tumors (2023)

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0 (2023)

SNMMI Procedure Standard/EANM Practice Guideline for Molecular Breast Imaging with Dedicated γ-Cameras (2022)

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0 (2022)

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds (2022)

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer (2022)

Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0. (2022)

EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA) (2021)

 E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET (2021)

 EANM / SNMMI Practice Guideline for [18F]FDG PET/CT External Beam Radiotherapy Treatment Planning in Uterine Cervical Cancer (2020)

[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0 (2019) 

The EAU – EANM – ESTRO – ESUR – SIOG Guidelines on Prostate Cancer (2019) 

EANM Practice Guideline/SNMMI Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma (2019)

The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma (2018)

 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 (2017)

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (2017)

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (2017)

EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma (2015)
in cooperation with the European Society of Surgical Oncology (ESSO) and the European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group. endorsed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI)

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 (2014)

The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers (2014)

EANM/SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer (2013)

Integration of FDG-PET/CT into external beam radiation therapy planning (2012)

Breast scintigraphy with breast specific gamma cameras 1.0 (2010)

This website uses cookies. Learn more